NCT05188456

Brief Summary

This is a cross-sectional research. The Protection Motivation Theory (PMT) was applied as theoretical framework to analyze correlation of prevention knowledge, prevention intentions and anxiety, and prevention behavior of COVID-19 and HIV risk feature and behavior and stigma of people living with HIV/AIDS (PLWHA), and HIV high-risk groups. Purposive and snowball sampling will be applied to recruit participant who visit hospital, HIV/AIDS related institutions, and social media platforms. The investigators expect that the outcome could reveal the relationship of cognition and attitude of COVID-19 to HIV prevention and treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 12, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

January 13, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

April 24, 2023

Status Verified

April 1, 2023

Enrollment Period

1.5 years

First QC Date

January 10, 2022

Last Update Submit

April 20, 2023

Conditions

COVID-19 PandemicsHuman Immunodeficiency Virus

Keywords

AttitudeBehaviorCoronavirus disease 19 (COVID-19)HIV high risk groupKnowledgePeople living with HIV/AIDS (PLWHA)Protection Motivation Theory (PMT)Stigma

Outcome Measures

Primary Outcomes (5)

  • COVID-19 prevention knowledge

    The questionnaire of COVID-19 prevention knowledge will be used to measure the knowledge level.

    Through study completion, an average of one and half year

  • COVID-19 prevention intention and anxiety

    The questionnaire of COVID-19 prevention intention and anxiety will be used to measure the attitude level.

    Through study completion, an average of one and half year

  • COVID-19 prevention behavior

    The questionnaire of COVID-19 prevention behavior will be used to measure the behavior level.

    Through study completion, an average of one and half year

  • Stigma

    The questionnaire of stigma will be used to measure the stigma level of HIV infected people.

    Through study completion, an average of one and half year

  • HIV risk factor and behavior

    The questionnaire of HIV risk factor and behavior will be used to measure the risk condition during COVID-19 era.

    Through study completion, an average of one and half year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Two study populations will be incruited in this research: 1. Those who had been diagnosed with HIV/AIDS. 2. Those who self-idenftified as HIV high risk group, such as having unsafe sex experience or injecting drug user.

You may qualify if:

  • Participants who diagnosed with HIV/AIDS.
  • Age over 18 years old.
  • Participants who can read and communicate.

You may not qualify if:

  • \. Participants who can't read and communicate.
  • Participants who have experienced unsafe sex, regardless of their gender orientation, such as those who describe themselves as men who have sex with men (MSM), heterosexuals, transgender, sex workers, etc.
  • Injecting Drug User(IDU)
  • Age over 18 years old.
  • Participants who can read and communicate.
  • \. Participants who can't read and communicate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Nursing of National Taiwan University

Taipei, 100, Taiwan

RECRUITING

MeSH Terms

Conditions

COVID-19Acquired Immunodeficiency SyndromeBehaviorSocial Stigma

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesHIV InfectionsBlood-Borne InfectionsCommunicable DiseasesSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesSocial Behavior

Central Study Contacts

PIAO-YI CHIOU, doctoral

CONTACT

+886-2-23123456piaoyi@ntu.edu.tw

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 10, 2022

First Posted

January 12, 2022

Study Start

January 13, 2022

Primary Completion

June 30, 2023

Study Completion

July 31, 2023

Last Updated

April 24, 2023

Record last verified: 2023-04

Locations

TW(1)